APA (7th ed.) Citation

Burudpakdee, C., & Bertwistle, D. (2012). PCN94 Feasibility of Efficiency Frontier Analysis (EFA) in Metastatic Breast Cancer (mBC) Treatments: A UK Perspective. Value in Health, 15(7), A426. https://doi.org/10.1016/j.jval.2012.08.2134

Chicago Style (17th ed.) Citation

Burudpakdee, C., and D. Bertwistle. "PCN94 Feasibility of Efficiency Frontier Analysis (EFA) in Metastatic Breast Cancer (mBC) Treatments: A UK Perspective." Value in Health 15, no. 7 (2012): A426. https://doi.org/10.1016/j.jval.2012.08.2134.

MLA (9th ed.) Citation

Burudpakdee, C., and D. Bertwistle. "PCN94 Feasibility of Efficiency Frontier Analysis (EFA) in Metastatic Breast Cancer (mBC) Treatments: A UK Perspective." Value in Health, vol. 15, no. 7, 2012, p. A426, https://doi.org/10.1016/j.jval.2012.08.2134.